03:25 PM EDT, 08/12/2024 (MT Newswires) -- Abeona Therapeutics ( ABEO ) shares gained more than 16% in recent Monday trading after the company posted a narrower Q2 loss.

The company reported earlier Monday a Q2 loss of $0.26 per diluted share, narrower than a loss of $0.92 a year earlier.

Analysts polled by Capital IQ expected a loss of $0.36.

No revenue was reported for the quarter ended June 30, compared with $3.5 million a year earlier.

As of June 30, the company said it had $123 million in cash, cash equivalents, short-term investments and restricted cash.

Price: 5.15, Change: +0.73, Percent Change: +16.40